Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Combination of Hypoxia-Preconditioned ADSCs and Deferoxamine Can Speed Up the Healing of Diabetic Wounds by Promoting Angiogenesis and Regulating Macrophage Polarization.

Cai F., Chen W., Li Q., Chen S., Xu Y., Ren Y.

Animal Study on Diabetic Foot, Chronic Wound, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Stem Cell Rev Rep (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41691122
DOI
10.1007/s12015-026-11083-y

Abstract (original English)

Transplanting hypoxic prestimulated adipose-derived stem cells (ADSCs) is an effective solution for promoting diabetic wound healing. However, ADSCs may experience a reduction in their biological functions when exposed to high glucose levels, which is important to note. Therefore, this study utilized deferoxamine (DFO) to induce a hypoxic microenvironment in mice in order to maintain and promote the effectiveness of ADSCs in treating diabetic wounds. In this study, elevated glucose levels negatively impact ADSCs, but DFO improves viability, secretion, and differentiation. Additionally, ADSCs can also inhibit the polarization of macrophages to M1 by up-regulating HSP70 and inhibiting NF-κB, and promote the polarization of macrophages to the M2 phenotype. Significantly, combining ADSCs with DFO led to a greater enhancement in their ability to promote angiogenesis and regulate macrophage polarization. In the in vivo study, it was observed that compared to the individual use of DFO or ADSCs, their combined use had a significant impact on enhancing the healing of diabetic wounds. These results demonstrated that the application of DFO can effectively reduce the detrimental effects of high glucose on ADSCs, thereby boosting their function in promoting angiogenesis and managing macrophage polarization, and improving the healing of diabetic wounds.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
DeferoxamineAnimalsWound HealingMacrophagesNeovascularization, PhysiologicMiceDiabetes Mellitus, ExperimentalAdipose TissueCell DifferentiationStem Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research